PURPOSE: Postoperative ileus (POI) impairs patient recovery, prolonging hospital stay after major surgery in ovarian cancer (OvCa) patients. Thus, intraoperative bowel isolation is expected to reduce manipulation-related impairment. The aim of this study was to investigate the impact of intraoperative intestinal isolation bag on POI in OvCa patients submitted to primary surgery.METHODS: A randomized trial including patients managed with or without isolation bag during OvCa primary surgery was conducted. Patients were selected by consecutive randomization. Primary endpoints were the time between surgery and resumption of bowel motility (as passage of first/continued flatus), assessing of postoperative nausea or vomiting and return to regular diet. Secondary endpoint was the impact of intestinal isolation bag on length of hospitalization in the two groups.RESULTS: Ninety-two patients respecting inclusion criteria were eligible to be enrolled in the study (48 patients as Group 1 and 44 patients as Group 2). Thirty-eight (79.2%) patients, in which intraoperative isolation bag was used, experienced first/continued flatus within 3days from surgery and they were susceptible to be discharged within 5days, compared, respectively, to 34.3% of Group 2 (n=15). Advantages were more evident in patients whose surgery took over 220min (OR 0.02, CI 95% 0.001-0.57; p<0.001) despite the type of surgical effort made.CONCLUSION: Despite the small sample size, our study showed that the use of intestinal isolation bag can reduce incidence of POI and length of stay in OvCa patients submitted to primary cytoreductive surgery.

Perutelli, A., Ferrandina, M. G., Domenici, L., Cubeddu, A., Garibaldi, S., Aretini, P., Mazzanti, C. M., Salerno, M. G., Modified intestinal isolation bag as promising tool in promoting bowel resumption after ovarian cancer cytoreductive surgery: a randomized clinical trial, <<ARCHIVES OF GYNECOLOGY AND OBSTETRICS>>, 2021; (N/A): N/A-N/A. [doi:10.1007/s00404-021-05981-4] [http://hdl.handle.net/10807/168536]

Modified intestinal isolation bag as promising tool in promoting bowel resumption after ovarian cancer cytoreductive surgery: a randomized clinical trial

Ferrandina, Maria Gabriella;
2021

Abstract

PURPOSE: Postoperative ileus (POI) impairs patient recovery, prolonging hospital stay after major surgery in ovarian cancer (OvCa) patients. Thus, intraoperative bowel isolation is expected to reduce manipulation-related impairment. The aim of this study was to investigate the impact of intraoperative intestinal isolation bag on POI in OvCa patients submitted to primary surgery.METHODS: A randomized trial including patients managed with or without isolation bag during OvCa primary surgery was conducted. Patients were selected by consecutive randomization. Primary endpoints were the time between surgery and resumption of bowel motility (as passage of first/continued flatus), assessing of postoperative nausea or vomiting and return to regular diet. Secondary endpoint was the impact of intestinal isolation bag on length of hospitalization in the two groups.RESULTS: Ninety-two patients respecting inclusion criteria were eligible to be enrolled in the study (48 patients as Group 1 and 44 patients as Group 2). Thirty-eight (79.2%) patients, in which intraoperative isolation bag was used, experienced first/continued flatus within 3days from surgery and they were susceptible to be discharged within 5days, compared, respectively, to 34.3% of Group 2 (n=15). Advantages were more evident in patients whose surgery took over 220min (OR 0.02, CI 95% 0.001-0.57; p<0.001) despite the type of surgical effort made.CONCLUSION: Despite the small sample size, our study showed that the use of intestinal isolation bag can reduce incidence of POI and length of stay in OvCa patients submitted to primary cytoreductive surgery.
2021
Inglese
Perutelli, A., Ferrandina, M. G., Domenici, L., Cubeddu, A., Garibaldi, S., Aretini, P., Mazzanti, C. M., Salerno, M. G., Modified intestinal isolation bag as promising tool in promoting bowel resumption after ovarian cancer cytoreductive surgery: a randomized clinical trial, <<ARCHIVES OF GYNECOLOGY AND OBSTETRICS>>, 2021; (N/A): N/A-N/A. [doi:10.1007/s00404-021-05981-4] [http://hdl.handle.net/10807/168536]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/168536
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact